Robert J. Spiegel - Jan 19, 2023 Form 3 Insider Report for Ayala Pharmaceuticals, Inc. (ADXS)

Role
Director
Signature
/s/ Robert J. Spiegel
Stock symbol
ADXS
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
3
Date filed
1/23/2023, 05:13 PM
Previous filing
Jan 17, 2023
Next filing
Apr 3, 2023

No securities are beneficially owned.